Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Consolidated Interim Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:        
Net loss for the period $ (10,266) $ (2,441) $ (17,082) $ (5,733)
Items not involving cash:        
Stock-based compensation 515 449 2,743 510
Shares issued to Aspire Capital as commitment fees (note 6(a)(iii)) 600 600
Depreciation and amortization 19 23 35 46
Interest income (74) (11) (118) (19)
Unrealized foreign exchange (loss) gain (29) 28 (50)
Change in non-cash operating working capital (note 8) (51) (631) 439 (47)
Cash used in operating activities (9,257) (2,640) (13,355) (5,293)
Cash flows from financing activities:        
Issuance of common shares under the 2018 ATM, net of issuance costs (note 6(a)(i)) 5,246 5,246
Issuance of common shares under Share Purchase Agreement (note 6(a)(ii)) 6,140 14,995
Issuance of common shares under the ATM, net of issuance costs (note 6(a)(iv)) 4,528 8,204
Issuance of common shares upon exercise of stock options (note 7) 183 183
Cash provided by financing activities 11,569 4,528 20,424 8,204
Cash flows from (used in) investing activities:        
Maturity (acquisition) of investments 250 (2,985) 250 (2,985)
Purchase of property and equipment (100) (124)
Interest received 74 11 118 19
Cash provided by (used in) investing activities 224 (2,974) 244 (2,966)
Effect of exchange rate fluctuations on cash and cash equivalents held 29 50
Increase (decrease) in cash and cash equivalents 2,536 (1,057) 7,313 (5)
Cash and cash equivalents, beginning of year 15,408 8,992 10,631 7,940
Cash and cash equivalents, end of year $ 17,944 $ 7,935 $ 17,944 $ 7,935